INSIGHT (R)XT. Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT

NCT00680550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1003

Last updated 2013-10-16

No results posted yet for this study

Summary

To describe the clinical indications for Reveal XT in diagnosis and continuous monitoring of arrhythmia and to explore the clinical applications and outcome of arrhythmia monitoring on patient care.

Conditions

Sponsors & Collaborators

  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Guido Rieger, MD · Medtronic Bakken Research Center BV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Austria
  • Belarus
  • Czechia
  • Finland
  • Germany
  • Italy
  • Netherlands
  • Portugal
  • Russia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00680550 on ClinicalTrials.gov